Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances

Acta Obstetricia et Gynecologica Scandinavica

Volumn 77, Issue 1, 1998, Pages 3-7

  Kostrzewska, Anna ^a   Laudanski, Tadeusz ^a   Steinwall, Margareta ^b   Bossmar, Thomas ^b   Gal, Claudine Serradeil Le ^c   Åkerlund, Mats ^b  

^a School of Medical Sciences   (Poland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SANOFI   (France)

Author keywords

Arginine vasopressin; Myometrial hyperactivity; Physiological and pathophysiological conditions; Uterine arteries

Indexed keywords

ARGIPRESSIN; ENDOTHELIN 1; INDOLE DERIVATIVE; NORADRENALIN; PROSTAGLANDIN F2 ALPHA; PYRROLIDINE DERIVATIVE; RELCOVAPTAN; VASOCONSTRICTOR AGENT; VASOPRESSIN RECEPTOR; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADULT; ARTERY; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; MIDDLE AGED; PHYSIOLOGY; UTERUS; VASCULARIZATION; VASOCONSTRICTION; DYSMENORRHEA; HUMAN TISSUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UTERINE ARTERY; UTERUS BLOOD FLOW; UTERUS CONTRACTION;

ADULT; ARGININE VASOPRESSIN; ARTERIES; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HUMANS; INDOLES; MIDDLE AGED; NOREPINEPHRINE; PYRROLIDINES; RECEPTORS, VASOPRESSIN; UTERUS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031594430     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.1998.770102.x     Document Type: Article

References (18)

1. Åkerlund M, Strömberg P, Forsling ML. Primary dysmenorrhea and vasopressin. Br J Obstet Gynaecol 1979; 86: 484-7.
2. Strömberg P, Åkerlund M, Forsling ML, Granström E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and in primary dysmenorrhea. Acta Obstet Gynecol Scand 1984; 63: 533-8.
3. Ekström P, Åkerlund M, Forsling M, Kindahl H, Laudanski T, Mrugacz G. Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment - effect of uterine contractility. Br J Obstet Gynaecol 1992; 99: 680-4.
4. Jard S, Elands J, Schmidt A, Barberis C. Vasopressin and oxytocin receptors: an overview. In: Progress in Endocrinology. Imura H and Shizurne K, eds. Exerpta Medica, Amsterdam, 1988; 1183-8.
5. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem 1994; 269: 3304-10.
6. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA oncoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-92.
7. Bossmar T, Åkerlund M, Fantoni G, Szamatowicz J, Melin P, Maggi M. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist Atosiban. Am J Obstet Gynecol 1994; 171: 1634-42.
8. Bossmar T, Åkerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. Br J Obstet Gynaecol 1995; 102: 907-12.
9. Ekström P, Alm P, Åkerlund M. Differences in vasomotor responses between main stem and smaller branches of the human uterine artery. Acta Obstet Gynecol Scand 1991; 70: 429-33.
10. Kostrzewska A, Laudanski T, Batra S. Effect of ovarian steroids and diethylstilbestrol on the contractile responses of the human myometrium and intramyometrial arteries. Eur J Pharmacol 1993; 233: 127-34.
11. Kostrzewska A, Laudanski T, Batra S. Potent inhibition of tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries. Am J Obstet Gynecol 1997; 176: (in press).
12. 1a receptor antagonist, SR 49059, and its enantiomer, SR 49770, on isolated human myometrium. Acta Obstet Gynecol Scand 1996; 75: 516-19.
13. 1a vasopressin receptor antagonist on vasopressin-induced uterine contractions in women. Br J Obstet Gynaecol 1997; 104: 471-7.
14. Waud DR. Analysis of dose-response curves. In: Methods in Pharmacology, Daniel EE, Paton DM, eds. New York and London, Plenum Press 1975; vol. 3, ch. 27.
15. Arunlakshana O, Schildt HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58.
16. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-6.
17. Serradeil-Le-Gal C, Wagnon J, Garcia C, Lacour C, Guiraudou P, Christophe B et al. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptor. J Clin Invest 1994; 92: 224-31.
18. 1a antagonist, on human vascular smooth muscle cells. Am J Physiol (Heart Circ. Physiol 37) 1995; 268: H404-410.